Once-Daily Tacrolimus Extended-Release Formulation: 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients

It is speculated that a once-daily dosage of immunosuppression can increase adherence and thereby graft survival. Until now, there have been no studies on once-daily use of Tacrolimus extended-release formulation (TAC-ER) in children following pediatric kidney transplantation. In 11 stable pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Pape, Lars, Heidotting, Nele, Ahlenstiel, Thurid
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106355/
https://www.ncbi.nlm.nih.gov/pubmed/21647310
http://dx.doi.org/10.4061/2011/126251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106355/
https://www.ncbi.nlm.nih.gov/pubmed/21647310
http://dx.doi.org/10.4061/2011/126251

Ejemplares similares